Myelodysplastic Syndrome (MDS) develops due to malformed or dysfunctional blood cells. People with this condition have cells that die in the bone marrow or before entering the blood stream. This results in problems such as anemia, infection and excess bleeding. MDS represents a group of disorders and rarely displays signs or symptoms in the early stages. Over time, myelodysplastic syndromes may cause fatigue, paleness, easy bruising or bleeding, pinpoint-sized red dots (petechiae) and frequent infections. Treatments for myelodysplastic syndrome aim to slow the progression of the disease and help manage symptoms. These may include blood transfusions, medication and bone marrow or stem cell transplants.